An FDA-cleared artificial intelligence-based tool had lower positive predictive values and sensitivity when used for intracranial hemorrhage detection, compared with previous studies, according to a study in a radiology journal. The findings, which showed an association between lower performance and a neurosurgery history and ICH features, "further highlight the need for standardized study design to allow for rigorous and reproducible site-to-site comparison of emerging deep learning technologies," study authors wrote.
Study: Standardize evaluation of AI-based CDS tools
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.